Literature DB >> 31938963

Mental and physical health status among chronic hepatitis B patients.

Yihe G Daida1, Joseph A Boscarino2, Anne C Moorman3, Mei Lu4, Loralee B Rupp4, Stuart C Gordon4,5, Eyasu H Teshale6, Mark A Schmidt7, Philip R Spradling3.   

Abstract

PURPOSE: Little is known about health-related quality of life (HRQoL) in patients with chronic hepatitis B virus (CHB) infection in the United States. Our goal is to understand factors associated with HRQoL in this population.
METHODS: We conducted a survey to assess HRQoL and behavioral risks among patients with CHB infection from four large U.S. health care systems. Primary outcomes were generated from the SF-8 scale to assess HRQoL, as measured by the mental component scores (MCS) and physical component scores (PCS). The survey also measured socio-demographic information, hepatitis-related behavioral risk factors, treatment exposure/history, stress, and social support. We supplemented survey data with electronic health records data on patient income, insurance, disease severity, and comorbidities. Multivariate analysis was used to estimate and compare adjusted least square means of MCS and PCS, and examine which risk factors were associated with lower MCS and PCS.
RESULTS: Nine hundred sixty-nine patients (44.6%) responded to the survey. Current life stressors and unemployment were associated with both lower MCS and PCS results in multivariate analyses. Lower MCS was also associated with White race and low social support, while lower PCS was also associated with Medicaid insurance.
CONCLUSIONS: Stressful life events and unemployment were related to mental and physical health status of CHB patients. Those who have social support have better mental health; White and Medicaid patients are more likely to have poorer mental and physical health, respectively. Management of CHB patients should include stress management, social support, and financial or employment assistance.

Entities:  

Keywords:  CHB; Chronic; HRQoL; Hepatitis; SF-8

Mesh:

Year:  2020        PMID: 31938963      PMCID: PMC8281322          DOI: 10.1007/s11136-020-02416-6

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  41 in total

1.  Transforming insurance coverage into quality health care: voltage drops from potential to delivered quality.

Authors:  J M Eisenberg; E J Power
Journal:  JAMA       Date:  2000-10-25       Impact factor: 56.272

2.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

3.  Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence.

Authors:  Philip R Spradling; Loralee Rupp; Anne C Moorman; Mei Lu; Eyasu H Teshale; Stuart C Gordon; Cynthia Nakasato; Joseph A Boscarino; Emily M Henkle; David R Nerenz; Maxine M Denniston; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-08-08       Impact factor: 9.079

4.  Health state utilities and quality of life in patients with hepatitis B.

Authors:  Gloria Woo; George Tomlinson; Colina Yim; Les Lilly; George Therapondos; David K H Wong; Wendy J Ungar; Thomas R Einarson; Morris Sherman; Jenny E Heathcote; Murray Krahn
Journal:  Can J Gastroenterol       Date:  2012-07       Impact factor: 3.522

5.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

6.  The Social Readjustment Rating Scale.

Authors:  T H Holmes; R H Rahe
Journal:  J Psychosom Res       Date:  1967-08       Impact factor: 3.006

7.  Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work.

Authors:  Steven R Austin; Yu-Ning Wong; Robert G Uzzo; J Robert Beck; Brian L Egleston
Journal:  Med Care       Date:  2015-09       Impact factor: 2.983

8.  Screening for problem drinking: comparison of CAGE and AUDIT. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K A Bradley; K R Bush; M B McDonell; T Malone; S D Fihn
Journal:  J Gen Intern Med       Date:  1998-06       Impact factor: 5.128

9.  Racial-Ethnic Differences in Psychiatric Diagnoses and Treatment Across 11 Health Care Systems in the Mental Health Research Network.

Authors:  Karen J Coleman; Christine Stewart; Beth E Waitzfelder; John E Zeber; Leo S Morales; Ameena T Ahmed; Brian K Ahmedani; Arne Beck; Laurel A Copeland; Janet R Cummings; Enid M Hunkeler; Nangel M Lindberg; Frances Lynch; Christine Y Lu; Ashli A Owen-Smith; Connie Mah Trinacty; Robin R Whitebird; Gregory E Simon
Journal:  Psychiatr Serv       Date:  2016-04-15       Impact factor: 3.084

10.  Health-related quality of life in patients with chronic hepatitis B.

Authors:  Silvia Bondini; Jillian Kallman; Amy Dan; Zahra Younoszai; Lolita Ramsey; Fatema Nader; Zobair M Younossi
Journal:  Liver Int       Date:  2007-10       Impact factor: 5.828

View more
  4 in total

1.  Impact and Risk of Moral Injury Among Deployed Veterans: Implications for Veterans and Mental Health.

Authors:  Joseph A Boscarino; Richard E Adams; Tiah J Wingate; Joseph J Boscarino; Thomas G Urosevich; Stuart N Hoffman; H Lester Kirchner; Charles R Figley; William P Nash
Journal:  Front Psychiatry       Date:  2022-06-06       Impact factor: 5.435

2.  Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review.

Authors:  Lea Ladegaard Grønkjær; Mette Munk Lauridsen
Journal:  JHEP Rep       Date:  2021-09-28

3.  A Comprehensive Nursing Model Combined with High-Quality Nursing Intervention for Antiviral Therapy in Patients with Chronic Hepatitis B.

Authors:  Wei Yang; Xiaofeng Tian; Jing Liang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-08       Impact factor: 2.650

4.  Genetic and Psychosocial Risk Factors Associated with Suicide Among Community Veterans: Implications for Screening, Treatment and Precision Medicine.

Authors:  Joseph A Boscarino; Richard E Adams; Thomas G Urosevich; Stuart N Hoffman; H Lester Kirchner; Xin Chu; Weixing Shi; Joseph J Boscarino; Ryan J Dugan; Carrie A Withey; Charles R Figley
Journal:  Pharmgenomics Pers Med       Date:  2022-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.